drug

cabazitaxel

1 story · latest Oct 30, 2026

Follow cabazitaxel. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Jun 2010 · NDA201023
Brands: Jevtana, Jevtana Kit
Trials: 2 registered trials in coverage

Relationships

Developed by Sanofi

Timeline

Merck registers new MK-8644 psoriasis trial; RA and HIV/HPV vaccine trials continue

Oct 30Weekly roundup, 11 itemscabazitaxel dexamethasoneUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.